Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Agilent Technologies, Inc. (A)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
134.57-3.55 (-2.57%)
At close: 04:02PM EST
133.70 -0.87 (-0.65%)
After hours: 05:25PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Hammer

Hammer

Previous Close138.12
Open135.36
Bid131.90 x 1400
Ask135.50 x 900
Day's Range132.65 - 136.62
52 Week Range112.47 - 179.57
Volume1,634,222
Avg. Volume1,693,727
Market Cap40.64B
Beta (5Y Monthly)1.00
PE Ratio (TTM)34.15
EPS (TTM)3.94
Earnings DateFeb 22, 2022
Forward Dividend & Yield0.84 (0.61%)
Ex-Dividend DateJan 03, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for A

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Agilent Technologies, Inc.
    Analyst Report: Agilent Technologies, Inc.Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
  • Zacks

    Here's Why Agilent (A) Could be Great Choice for a Bottom Fisher

    Agilent (A) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

  • Business Wire

    Agilent Announces the Innovative Seahorse XF Pro Analyzer

    SANTA CLARA, Calif., January 24, 2022--Agilent Technologies Inc. (NYSE: A) today announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools. With enhanced performance, more robust and efficient workflows, and an optimized user experience, the XF Pro enables operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fat

  • GuruFocus.com

    Strategic Wealth Investment Group, LLC Buys Vanguard Long-Term Bond ETF, iShares TIPS Bond ETF, ...

    Investment company Strategic Wealth Investment Group, LLC (Current Portfolio) buys Vanguard Long-Term Bond ETF, iShares TIPS Bond ETF, Eli Lilly and Co, Cisco Systems Inc, International Business Machines Corp, sells Keysight Technologies Inc, Humana Inc, Agilent Technologies Inc, Truist Financial Corp, 3D Systems Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Strategic Wealth Investment Group, LLC.

Advertisement
Advertisement